(HealthDay News) – Use of intermediate-acting non-depolarizing neuromuscular blocking agents during general anesthesia is associated with an increase in the risk of postoperative respiratory ...
The batch was distributed between August 14, 2018 and September 5, 2018. Neostigmine Methylsulfate Injection, a cholinesterase inhibitor, is indicated to reverse the effects of non-depolarizing ...
Perioperative anaphylaxis due to neuromuscular blocking agents occurred in roughly 58 per 100,000 administrations, with nearly 20% of cases associated with morbidity. Most patients recovered fully, ...
It is important to understand the principles of normal neuromuscular transmission when using neuromuscular blocking agents. The neuromuscular junction consists of the motor-nerve terminus, the ...
Neuromuscular blocking agents are frequently administered to pigs used for research. In humans, administration of the drugs is not without risk and may result in accidental awareness under general ...
SAN FRANCISCO — A novel nondepolarizing neuromuscular blocking agent is potent and has intermediate duration of action during general anesthesia maintained with sevoflurane and nitrous oxide, ...
The benefits of early continuous neuromuscular blockade in patients with acute respiratory distress syndrome (ARDS) who are receiving mechanical ventilation remain unclear. We randomly assigned ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results